Evidence map›Paper›PMID 31225466›Full record

ReviewCell stress2018

The emerging role of minor intron splicing in neurological disorders.

Daniel Jutzi, Maureen V Akinyi, Jonas Mechtersheimer, Mikko J Frilander, Marc-David Ruepp

Open access · goldAbstract readReview
In one paragraph

Review in Cell stress, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pathogenic variants in RNPC3 are associated with hypopituitarism and primary ovarian insufficiency.Genetics in medicine : official journal of the American College of Medical Genetics · 2022
    Article
  6. Alternative Splicing in Human Biology and Disease.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  7. Article
  8. Variants inHGG advances · 2021
    Article
  9. Minor Intron Splicing from Basic Science to Disease.International journal of molecular sciences · 2021
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Molecular and Cellular Mechanisms Affected in ALS.Journal of personalized medicine · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Daniel JutziDepartment of Chemistry and Biochemistry, University of Bern, CH-3012 Bern, Switzerland.
Maureen V AkinyiInstitute of Biotechnology, University of Helsinki, FI-00014, Finland.
Jonas MechtersheimerDepartment of Chemistry and Biochemistry, University of Bern, CH-3012 Bern, Switzerland.
Mikko J FrilanderInstitute of Biotechnology, University of Helsinki, FI-00014, Finland.
Marc-David RueppDepartment of Chemistry and Biochemistry, University of Bern, CH-3012 Bern, Switzerland.
University of Bern · CHHelsinki Institute of Physics · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pre-mRNA splicing is an essential step in eukaryotic gene expression. Mutations in

Indexed as

ALSFUSminor spliceosomeneurodegenerationpre-mRNA splicingSMATDP-43

Identifiers

PMID31225466
PMCPMC6558932
OpenAlexW2792078434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.